Результаты GEO Group превзошли ожидания, но акции упали из-за снижения прогноза

GEO Group's second quarter was marked by contract-driven growth and a significant expansion in federal partnerships, but the market responded negatively despite results that exceeded Wall Street's expectations. Management attributed the strong revenue and profit gains to new and expanded contracts with agencies like ICE and the US Marshals Service, particularly noting increased facility activations and a shift toward more intensive monitoring in its ISAP program. CEO George Zoley emphasized that "our better than expected performance reflects significant revenue growth from the contracts that we entered into throughout 2025," highlighting the impact of last year's record new business wins and recent policy changes affecting facility utilization. Is now the time to buy GEO? Find out in our full research report (it's free). GEO Group (GEO) Q2 CY2026 Highlights: - Revenue: $732.1 million vs analyst estimates of $721.8 million (15.1% year-on-year growth, 1.4% beat) - EPS (GAAP): $0.36 vs analyst estimates of $0.29 (26.2% beat) - Adjusted EBITDA: $142 million vs analyst estimates of $132.9 million (19.4% margin, 6.9% beat) - The company dropped its revenue guidance for the full year to $3 billion at the midpoint from $3.03 billion, a 0.8% decrease - EPS (GAAP) guidance for the full year is $1.30 at the midpoint, beating analyst estimates by 6.4% - EBITDA guidance for the full year is $555 million at the midpoint, above analyst estimates of $538.6 million - Operating Margin: 13.9%, up from 11.3% in the same quarter last year - Market Capitalization: $4.06 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Our Top 5 Analyst Questions From GEO Group's Q2 Earnings Call - Joe Gomes (NOBLE Capital): Asked about the reasons behind the one-year delay of Florida facility contracts and the impact on prior revenue guidance. CEO George Zoley confirmed the delay was due to unresolved budget issues, and that prior guidance included some expected revenues from these facilities. - Gomes (NOBLE Capital): Inquired whether ICE's reimbursement for capital expenditures in new contracts was a new practice and how it affects future CapEx. Zoley explained it is relatively new and reduces the need for unusual startup CapEx going forward. - Gomes (NOBLE Capital): Questioned prospects for growth in the ISAP program, given flat participant numbers. Zoley indicated ICE's current focus is on increasing detention capacity but noted ISAP could grow rapidly if policy shifts. - Brendan McCarthy: Asked if ICE must reach 100,000 detention beds before expanding ISAP and about the outlook for the skip tracing contract. Zoley confirmed the agency's focus on 100,000 beds and expects the skip tracing contract to begin ramping in the second half of the year. - Greg Gibas (Northland Securities): Sought details on post-asset sale capital allocation and leverage targets. CFO Shayn March indicated proceeds would be used for debt repayment and potentially share repurchases, subject to debt agreement restrictions.